Enoxaparin thromboprophylaxis effective after hip replacement .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group
J Bone Joint Surg Am. 2001 Mar;83-A(3):336-45873 patients who had undergone elective total hip or knee replacement were randomized to receive 3 weeks of treatment with either enoxaparin or a placebo. This treatment was after subcutaneous injections of enoxaparin administered 7-10 days postoperatively to all patients. The primary outcome was the prevalence of venous thromboembolism or symptomatic pulmonary embolism during the treatment phase. Additional enoxaparin significantly reduced the prevalence of venous thromboembolism in comparison with placebo. This effect was not seen in patients with knee replacement.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
